Table 4. Clinicopathologic characteristics of patients with NSCLC.
| All cases (%) | All cases (%) | ||
|---|---|---|---|
| Age(years) | Gender | ||
| ≤ 50 | 91 (31.16) | Male | 213 (72.95) |
| > 50 | 201 (68.84) | Female | 79 (27.06) |
| Differentiation degree | Clinical stage | ||
| Well | 79 (27.06) | I | 93 (31.85) |
| Moderately | 141 (48.29) | II | 103 (35.27) |
| Poorly | 72 (24.66) | III | 57 (19.52) |
| IV | 39 (13.36) | ||
| T Classification | N Classification | ||
| T1 | 107 (36.64) | N0 | 159 (54.45) |
| T2 | 95 (32.53) | N1 | 98 (33.56) |
| T3 | 69 (23.63) | N2 | 19 (6.51) |
| T4 | 21 (7.19) | N3 | 16 (5.48) |
| Distant metastasis | Smoking | ||
| M0 | 253 (86.64) | Yes | 189 (64.73) |
| M1 | 39 (13.36) | No | 103 (35.27) |
| Vital status (at follow-up) | Expression level of CTHRC1 | ||
| Alive | 37 (12.67) | Low expression | 80 (27.40) |
| Death | 255 (87.33) | High expression | 212 (72.60) |
| EGFR mutation | K-ras mutation | ||
| Positive | 46 (47.42) | Positive | 14 (14.43) |
| Negative | 51 (52.58) | Negative | 83 (85.57) |